Related references
Note: Only part of the references are listed.SWI/SNF complex-deficient soft tissue neoplasms: An update
Inga-Marie Schaefer et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2021)
Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases
Dorthe Holdhof et al.
ACTA NEUROPATHOLOGICA (2021)
SMARCA4-deficient Uterine Sarcoma and Undifferentiated Endometrial Carcinoma Are Distinct Clinicopathologic Entities
David L. Kolin et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Loss of BRG1 (SMARCA4) Immunoexpression in a Pediatric Non-Central Nervous System Tumor Cohort
Jessica Saunders et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2020)
Molecular subgrouping of atypical teratoid/rhabdoid tumors-a reinvestigation and current consensus
Ben Ho et al.
NEURO-ONCOLOGY (2020)
The SWI/SNF complex in cancer - biology, biomarkers and therapy
Priya Mittal et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines
Katharina Ehrenhoefer-Woelfer et al.
SCIENTIFIC REPORTS (2019)
Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy
Erika Zernickel et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4)
Christine Bookhout et al.
NEUROPATHOLOGY (2018)
Modular Organization and Assembly of SWI/SNF Family Chromatin Remodeling Complexes
Nazar Mashtalir et al.
CELL (2018)
Atypical teratoid rhabdoid tumor in the first year of life: the Canadian ATRT registry experience and review of the literature
Mary Fossey et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior
Jennifer L. Sauter et al.
MODERN PATHOLOGY (2017)
The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers
Burak H. Alver et al.
NATURE COMMUNICATIONS (2017)
Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type
Anthony N. Karnezis et al.
JOURNAL OF PATHOLOGY (2016)
SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2
Abbas Agaimy et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors
Christine M. Fillmore et al.
NATURE (2015)
Rhabdoid Tumor Predisposition Syndrome
Simone T. Sredni et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2015)
SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosis
Martin Hasselblatt et al.
ACTA NEUROPATHOLOGICA (2014)
Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis
Li Li et al.
HUMAN PATHOLOGY (2014)
Residual Complexes Containing SMARCA2 (BRM) Underlie the Oncogenic Drive of SMARCA4 (BRG1) Mutation
Boris G. Wilson et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
A Synthetic Lethality-Based Strategy to Treat Cancers Harboring a Genetic Deficiency in the Chromatin Remodeling Factor BRG1
Takahiro Oike et al.
CANCER RESEARCH (2013)
Inhibition of the Stem Cell Marker Nestin Reduces Tumor Growth and Invasion of Malignant Melanoma
Michiko Akiyama et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
Cigall Kadoch et al.
NATURE GENETICS (2013)
Nestin Expression Identifies Ependymoma Patients with Poor Outcome
Till Milde et al.
BRAIN PATHOLOGY (2012)
Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system
Christelle Dufour et al.
CANCER (2012)
Nonsense Mutation and Inactivation of SMARCA4 (BRG1) in an Atypical Teratoid/Rhabdoid Tumor Showing Retained SMARCB1 (INI1) Expression
Martin Hasselblatt et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Inducible expression of stem cell associated intermediate filament nestin reveals an important role in glioblastoma carcinogenesis
Wen Jing Lu et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Germline Nonsense Mutation and Somatic Inactivation of SMARCA4/BRG1 in a Family with Rhabdoid Tumor Predisposition Syndrome
Reinhard Schneppenheim et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
Nestin is essential for mitogen-stimulated proliferation of neural progenitor cells
Xiao-jing Xue et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2010)
The role of SMARCB1/INI1 in development of rhabdoid tumor
Charles W. M. Roberts et al.
CANCER BIOLOGY & THERAPY (2009)
The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells
S. R. Naidu et al.
ONCOGENE (2009)
Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival
Tadej Strojnik et al.
SURGICAL NEUROLOGY (2007)
Nestin expression in cutaneous melanomas and melanocytic nevi
Svetlana Brychtova et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2007)
A nestin scaffold links Cdk5/p35 signaling to oxidant-induced cell death
Cecilia M. Sahlgren et al.
EMBO JOURNAL (2006)
Central nervous system atypical teratoid/rhabdoid tumor: Results of therapy in children enrolled in a registry
JM Hilden et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Patterns of nestin and other intermediate filament expression distinguish between gastrointestinal stromal tumors, leiomyomas and schwannomas
M Sarlomo-Rikala et al.
APMIS (2002)
Atypical teratoid/rhabdoid tumor of the central nervous system: Report on workshop
RJ Packer et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2002)
Immunohistochemical detection of nestin in pediatric brain tumors
PM Almqvist et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2002)